OSCR
Oscar Health Inc
NYSE: OSCR · HEALTHCARE · HEALTHCARE PLANS
$17.93
-0.61% today
Updated 2026-04-29
Market cap
$5.40B
P/E ratio
—
P/S ratio
0.46x
EPS (TTM)
$-1.69
Dividend yield
—
52W range
$11 – $24
Volume
6.5M
Oscar Health Inc (OSCR) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | $553.78M | $589.64M | $1.92B | $4.13B | $5.86B | $9.18B | $11.70B |
| Revenue growth (YoY) | — | +6.5% | +225.8% | +114.8% | +42.1% | +56.5% | +27.5% |
| Cost of revenue | — | — | — | — | $4.64B | $7.33B | $10.02B |
| Gross profit | $553.78M | $589.64M | $1.92B | $4.13B | $5.86B | $1.84B | $1.68B |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 20.1% | 14.4% |
| R&D | — | — | — | — | — | — | — |
| SG&A | $110.68M | $166.66M | $265.08M | $1.42B | $339.72M | $1.76B | $2.05B |
| Operating income | $-259.39M | $-405.78M | $-570.58M | $-610.08M | $-235.62M | $57.27M | $-396.36M |
| Operating margin | -46.8% | -68.8% | -29.7% | -14.8% | -4.0% | 0.6% | -3.4% |
| EBITDA | $-252.49M | $-390.98M | $-551.25M | $-572.17M | $-235.62M | $89.31M | $-391.05M |
| EBITDA margin | -45.6% | -66.3% | -28.7% | -13.9% | -4.0% | 1.0% | -3.3% |
| EBIT | $-259.39M | $-402.27M | $-565.86M | $-587.45M | $-235.62M | $57.16M | $-419.94M |
| Interest expense | $0.00 | $3.51M | $4.72M | $22.62M | $24.60M | $23.73M | $17.60M |
| Income tax | $1.79M | $1.04M | $846000.00 | $-523000.00 | $3.29M | $7.30M | — |
| Effective tax rate | -0.7% | -0.3% | -0.1% | 0.1% | -1.2% | 22.3% | 0.0% |
| Net income | $-261.18M | $-406.82M | $-572.61M | $-606.27M | $-270.73M | $25.43M | $-443.15M |
| Net income growth (YoY) | — | -55.8% | -40.7% | -5.9% | +55.3% | +109.4% | -1842.5% |
| Profit margin | -47.2% | -69.0% | -29.8% | -14.7% | -4.6% | 0.3% | -3.8% |